Tessera Defense & Homeland Security (HLSQ)Director sold ~$10.5M

~$10.5M

Approx. value · 2M sh @ $5.24

1.7M

Holds after · shares reported

Traded

Mar 16, 2026

Filed

Mar 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 4, 2026Company filing · Form 8-K · Acquisition or sale, Executive changeCompleted buying or selling a business or assets, and changed a top executive or board member“As described in Item 2.01 above, on February 4, 2026, BiomX Ltd.’s Chief Executive Officer, Jonathan Solomon, and Chief Financial Officer, Marina Wolfson, were notified that their role as officers of BiomX Ltd. had been terminated, retroactive to January 25, 2026.”
2. Feb 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 9, 2026, and February 11, 2026, Jonathan Leff and Jesse Goodman resigned from the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), for personal reasons, each effective immediately.”
3. Feb 19, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 19, 2026, Alan Moses resigned from the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), for personal reasons, effective immediately. Mr. Moses did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.”
4. Feb 24, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On February 24, 2026, (i) Marina Wolfson tendered her resignation as the Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of BiomX Inc. (the “Company”) and (ii) Dr. Merav Bassan tendered her resignation as the Chief Development Officer of the Company, in each case, effective as of the same date.”
5. Mar 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 4, 2026, Jonathan Solomon resigned (i) from the board of directors (the “Board”) of BiomX Inc. (the “Company”) and from all Board committees thereto and (ii) from his position as Chief Executive Officer and Chief Principal Officer of the Company, in each case, effective immediately.”
6. Mar 12, 2026Insider · 13 days before an 8-KDirector sold ~$1.5M of HLSQ shares in the open market
7. Mar 13, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
8. Mar 13, 2026Insider · 12 days before an 8-KDirector sold ~$1.85M of HLSQ shares in the open market
9. Mar 16, 2026 · this disclosureInsider · 9 days before an 8-KDirector sold ~$10.5M of HLSQ shares in the open market

What came next

1. Mar 16, 2026Insider · 1 personInsiders: 3 sales (~$16.8M)
2. Mar 17, 2026Insider · 8 days before an 8-KDirector sold ~$2.65M of HLSQ shares in the open market
3. Mar 25, 2026Company filing · Form 8-K · Listing notice, Other newsReceived a notice from its stock exchange, and reported other company news“On March 25, 2026, BiomX, Inc, a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0…”
4. Mar 31, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
5. Apr 10, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 2 more items)“On April 10, 2026, the Company completed the strategic acquisition of 100% of ZorroNet, a revenue-generating, operationally deployed Israeli AI defense technology company .”
6. Apr 13, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 2 more items)“The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.”
7. May 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 27, 2026, the Board of Directors of BiomX Inc. (“we,” “us,” “our,” “BiomX” or the “Company”) appointed Mr. Roy Rousso, to serve as the. Chief Business Officer, effective July 1, 2026.”
8. Jun 2, 2026Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
9. Jun 10, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On June 10, 2026, BiomX Inc. (the “Company”) received a written notice from NYSE Regulation stating that it had accepted the Company’s plan to regain compliance with the continued listing standards of the NYSE American LLC ("NYSE American").”
10. Jul 1, 2026Company filing · Form 8-K · Auditor changeChanged its auditor“On July 1, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of BiomX Inc. (the “Company”) determined, and the Board subsequently ratified and confirmed, to dismiss Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited (“PwC”), as the Company’s independent registered public accounting firm.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tessera Defense & Homeland Security

For Tessera Defense & Homeland Security, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HLSQ page.

Other recent filings by Reuven Yeganeh, Director

• SEC Form 4 at Tessera Defense & Homeland Security (HLSQ)Mar 19, 2026
• SEC Form 4 at Tessera Defense & Homeland Security (HLSQ)Mar 19, 2026
• SEC Form 4 at Tessera Defense & Homeland Security (HLSQ)Mar 19, 2026
• SEC Form 4 at Tessera Defense & Homeland Security (HLSQ)Mar 19, 2026
• SEC Form 4 at Tessera Defense & Homeland Security (HLSQ)Mar 14, 2026

The full history of Reuven Yeganeh, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Tessera Defense & Homeland Security

• SEC Schedule 13DOct 6, 2026
• SEC Schedule 13GOct 5, 2026
• SEC Form 4Mar 19, 2026
• SEC Form 4Mar 19, 2026
• SEC Form 4Mar 19, 2026
• SEC Form 4Mar 19, 2026

Everything OQRO holds on this company is on its HLSQ page.